These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22827237)

  • 1. The dynamic and changing epidemiology of meningococcal disease at the country-based level: the experience in Turkey.
    Dinleyici EC; Ceyhan M
    Expert Rev Vaccines; 2012 May; 11(5):515-8. PubMed ID: 22827237
    [No Abstract]   [Full Text] [Related]  

  • 2. Meningococci.
    Sippel JE
    Crit Rev Microbiol; 1981; 8(3):267-302. PubMed ID: 6781818
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum antibody level of meningococcal meningitis in health people in Hubei Province in 2003].
    Lu J; Lin FR; Liu L; Li XX; Li L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Nov; 25(11):996. PubMed ID: 15769339
    [No Abstract]   [Full Text] [Related]  

  • 4. Meningococcal disease, 1983-1989, British Columbia.
    Farley JD; Ng T; Smith JA; Shaw C
    Can Dis Wkly Rep; 1990 May; 16(18):86-8. PubMed ID: 2112044
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular characterization of Neisseria meningitidis B:NT:P1.14/162 clonal complex responsible of invasive meningococcal disease in the north of Italy.
    Neri A; Fazio C; Carannante A; Mastrantonio P; Stefanelli P
    Diagn Microbiol Infect Dis; 2012 Apr; 72(4):370-2. PubMed ID: 22313628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges for development of meningococcal vaccines in infants and children.
    Deasy A; Read RC
    Expert Rev Vaccines; 2011 Mar; 10(3):335-43. PubMed ID: 21434801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology and control of invasive meningococcal disease.
    Diaz PS
    Pediatr Infect Dis J; 1999 Jul; 18(7):633-4. PubMed ID: 10440442
    [No Abstract]   [Full Text] [Related]  

  • 8. High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil.
    Weidlich L; Baethgen LF; Mayer LW; Moraes C; Klein CC; Nunes LS; Rios Sda S; Kmetzsch CI; Rossetti ML; Zaha A
    J Infect; 2008 Oct; 57(4):324-31. PubMed ID: 18814914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002.
    Raghunathan PL; Jones JD; Tiendrebéogo SR; Sanou I; Sangaré L; Kouanda S; Dabal M; Lingani C; Elie CM; Johnson S; Ari M; Martinez J; Chatt J; Sidibe K; Schmink S; Mayer LW; Kondé MK; Djingarey MH; Popovic T; Plikaytis BD; Carlone GM; Rosenstein N; Soriano-Gabarró M
    J Infect Dis; 2006 Mar; 193(5):607-16. PubMed ID: 16453255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and pathogenesis of Neisseria meningitidis.
    Tzeng YL; Stephens DS
    Microbes Infect; 2000 May; 2(6):687-700. PubMed ID: 10884620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37.
    Krizova P; Musilek M
    Cent Eur J Public Health; 1995 Nov; 3(4):189-94. PubMed ID: 8903519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and meningococcal serogroup distribution in the United States.
    Hershey JH; Hitchcock W
    Clin Pediatr (Phila); 2010 Jun; 49(6):519-24. PubMed ID: 20507868
    [No Abstract]   [Full Text] [Related]  

  • 13. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
    Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
    Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing host susceptibility to meningococcal disease.
    Winstanley FP; Blackwell CC; Weir DM
    Biomed Pharmacother; 1985; 39(4):167-70. PubMed ID: 3933588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningococcal disease in Canada: 1991-92.
    Gold R
    Can J Public Health; 1992; 83(1):5-8. PubMed ID: 1571883
    [No Abstract]   [Full Text] [Related]  

  • 16. [Application of SP-RIA in the antibody surveillance and serologic diagnosis of epidemic cerebrospinal meningitis].
    Chen X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Dec; 14(6):366-70. PubMed ID: 8156584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of 2 Neisseria meningitidis serogroup C clones in a French county.
    Garnier F; Courouble M; Denis F; Ploy MC
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):280-2. PubMed ID: 21353952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory confirmed outbreak of meningococcal infections in Tripura.
    Majumdar T; Bhattacharya S; Barman D; Begum R
    Indian J Med Microbiol; 2011; 29(1):74-6. PubMed ID: 21304204
    [No Abstract]   [Full Text] [Related]  

  • 19. Meningococcal disease in New South Wales, 1991-2002.
    Hogan D; McAnulty J
    N S W Public Health Bull; 2004 Mar; 15(3):39-43. PubMed ID: 15124009
    [No Abstract]   [Full Text] [Related]  

  • 20. The epidemiology of meningococcal disease in India.
    Sinclair D; Preziosi MP; Jacob John T; Greenwood B
    Trop Med Int Health; 2010 Dec; 15(12):1421-35. PubMed ID: 21054695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.